Search

The aim of this study was to examine the use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI).The use of SVGs for retrograde crossing during CTO PCI has received limited study.A total of 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers were examined. Clinical, angiographic, and technical characteristics and procedural outcomes were compared among retrograde cases via SVGs (SVG group) versus other collateral vessels (non-SVG group).Retrograde CTO PCI via SVGs was performed in 189 cases (12%). Patients in the SVG group were older (mean age 70 ± 9 years vs. 64 ± 10 years; p 0.01) and had higher rates of prior myocardial infarction (62% vs. 51%; p 0.01) and prior PCI (81% vs. 70%; p 0.01). They were more likely to have moderate or severe calcification (81% vs. 65%; p 0.01) and moderate or severe tortuosity (53% vs. 44%; p = 0.02) and had similar J-CTO (Multicenter CTO Registry in Japan) scores (3.2 ± 1.0 vs. 3.1 ± 1.1; p = 0.13) but higher PROGRESS-CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) scores (4.7 ± 1.7 vs. 3.1 ± 1.1; p 0.01). Technical (85% vs. 78%; p = 0.04) and procedural (81% vs. 74%; p = 0.04) success rates were higher in the SVG group, with no difference in in-hospital major adverse events (6.4% vs. 4.4%; p = 0.22). Contrast volume was lower in the SVG group (225 ml [173 to 325 ml] vs. 292 ml [202 to 400 ml]; p 0.01).Use of SVGs for retrograde crossing is associated with higher rates of technical and procedural success and similar rates of in-hospital major adverse cardiac events compared with retrograde CTO PCI via other collateral vessels.

Chronic kidney disease (CKD) is an established predictor of more advanced peripheral artery disease (PAD) and vascular calcification. However, clinical outcome data for these patients remains inadequately defined. Using the ongoing multicenter Excellence in Peripheral Artery Disease (XLPAD)

Intravascular ultrasound (IVUS) is considered the gold standard in diagnosing common iliac vein (CIV) compression. The presence of more than 50% surface area reduction by IVUS is considered significant compression by most operators. In this study, we evaluate the role of computed tomographic

The use of saphenous vein grafts (SVGs) for retrograde crossing during chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. We examined 1,615 retrograde CTO PCIs performed between 2012 and 2019 at 25 centers. We compared the clinical, angiographic, and

It is unclear whether patients on oral anticoagulants (OAC) undergoing an endovascular procedure using common femoral artery (CFA) access have a higher rate of adverse events when compared to patients who are not anticoagulated with an OAC at the time of the procedure. We hypothesized that patients

There is significant uncertainty regarding stent or no-stent endovascular treatment of symptomatic peripheral artery disease involving the ostium of the superficial femoral artery (SFA). One hundred eighty-two patients with ostial SFA intervention were selected from the multicenter Excellence of

The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. We report 18-month target lesion revascularization (TLR) rates on patients treated for denovo femoropopliteal (FP) artery disease with JA in a single